The State of Immune Reactivity During the Treatment of Genital Herpes in Patients Who Have Undergone Covid-19

Authors

  • Guli A. Ismailova
  • Firuza B. Mirodilova
  • Nodira S. Saipova
  • Farkhod F. Hashimov
  • Gayratillo Sh. Tokhtaev
  • Azizbek F. Valijonov
  • Shirina A. Valijonova

DOI:

https://doi.org/10.47750/pnr.2022.13.S03.077

Keywords:

SARS-CoV-2, Recurrent Genital Herpes, HSV-1, HSV-2.

Abstract

Relapses of herpes simplex during the COVID-19 pandemic in patients with or without respiratory symptoms alarm us about the possibility of SARS-CoV-2 infection in these patients. Both the stress caused during the pandemic and the invasion of SARS-CoV-2 itself are generative elements of immunodeficiency in humans, a situation that can be used by the herpes virus to reactivate and infect the host (1)

Downloads

Published

2022-09-22

Issue

Vol. 13 SPECIAL ISSUE 03 (2022)

Section

Articles

How to Cite

The State of Immune Reactivity During the Treatment of Genital Herpes in Patients Who Have Undergone Covid-19. (2022). Journal of Pharmaceutical Negative Results, 472-475. https://doi.org/10.47750/pnr.2022.13.S03.077